Evidence map›Paper›PMID 42340655›Full record

ArticleLa Radiologia medica2026

High-fidelity super-resolution CT radiomics for non-invasive EGFR mutation prediction in lung adenocarcinoma: a multi-center pooled analysis.

Mao-Tong Liu, Tao Zhang, Ming Li

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mao-Tong LiuDepartment of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China.
Tao ZhangDepartment of Radiology, Affiliated Nantong Hospital 3 of Nantong University, Nantong, 226000, Jiangsu, People's Republic of China. 19931067@qq.com.
Ming LiDepartment of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, People's Republic of China. mingli19770506@163.com.

Funding

the Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0529300
6 · The paper itself

Abstract

objectiveTo develop and validate a high-fidelity super-resolution (SR)-enhanced radiomics framework using a Residual Channel Attention Network (RCAN) for non-invasive EGFR mutation prediction in lung adenocarcinoma (LUAD).

methodsThis retrospective multi-center study included 373 patients, partitioned into training (n = 298) and testing (n = 75) sets. CT images were reconstructed to a 1024 × 1024 matrix via RCAN to restore latent high-frequency textures. A standardized pipeline-including ComBat harmonization, ICC-based fidelity filtering, and LASSO regression-was employed to extract and select resolution-invariant features. Five machine learning classifiers were evaluated, and a combined nomogram integrated the SR-enhanced signature with clinical predictors. Model performance was assessed using AUC, DeLong tests, and decision curve analysis (DCA), with interpretability provided by SHAP analysis.

resultsThe SR-enhanced model significantly outperformed the original-resolution (OR) baseline, increasing the AUC from 0.60 (95% CI: 0.47-0.74) to 0.84 (95% CI: 0.75-0.93) in the testing set (P < 0.001). Consistent performance was maintained across imaging centers (P = 0.555) and histological subtypes. The combined nomogram achieved a robust AUC of 0.86 (95% CI: 0.78-0.94), demonstrating superior calibration and clinical net benefit. SHAP analysis revealed that glszm_ZoneVariance-a marker of intratumoral heterogeneity-was the predominant predictor revealed via SR reconstruction.

conclusionRCAN-driven SR reconstruction effectively addresses CT resolution limitations, capturing fine-grained radiogenomic signatures critical for molecular phenotyping. This high-fidelity framework offers a robust, non-invasive decision-support tool for personalized precision oncology in LUAD.

Indexed as

Deep learningEGFR mutationInterpretabilityLung adenocarcinomaRadiomicsSuper-resolution

Identifiers

PMID42340655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.